Alpha Cognition Inc. Amortization
Alpha Cognition Inc. (ACOG) reported Amortization of $57.50 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-03-31
- Alpha Cognition Inc. amortization for the quarter ending 2025-12-31 was $14.37K, a 27.26% decline year-over-year.
- Alpha Cognition Inc. amortization for the quarter ending 2025-09-30 was $14.42K, a 27.02% decline year-over-year.
- Alpha Cognition Inc. amortization for the quarter ending 2025-06-30 was $14.30K, a 27.63% decline year-over-year.
- Alpha Cognition Inc. amortization for the quarter ending 2025-03-31 was $14.40K, a 30.08% decline year-over-year.
- Alpha Cognition Inc. amortization for fiscal 2025 was $57.50K, a 28.02% decline from fiscal 2024.
- Alpha Cognition Inc. amortization for fiscal 2024 was $79.88K, a 3.04% decline from fiscal 2023.
- Alpha Cognition Inc. amortization for fiscal 2023 was $82.38K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $14.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $28.80K derived: sum of 2 quarters · filed 2026-03-31 | $43.10K derived: sum of 3 quarters · filed 2026-03-31 | $57.50K 10-K · filed 2026-03-31 |
| 2025-09-30 | $14.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $28.72K derived: sum of 2 quarters · filed 2025-11-13 | $43.12K 10-Q · filed 2025-11-13 | $62.88K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $14.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $28.70K 10-Q · filed 2025-08-14 | $48.46K derived: sum of 3 quarters · filed 2025-08-14 | $68.22K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $14.40K 10-Q · filed 2025-05-15 | $34.16K derived: sum of 2 quarters · filed 2025-05-15 | $53.92K derived: sum of 3 quarters · filed 2025-05-15 | $73.68K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $19.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $39.52K derived: sum of 2 quarters · filed 2025-03-31 | $59.28K derived: sum of 3 quarters · filed 2025-03-31 | $79.88K 10-K · filed 2025-03-31 |
| 2024-09-30 | $19.76K 10-Q · filed 2024-11-14 | $39.52K derived: sum of 2 quarters · filed 2024-11-14 | $60.12K 10-Q · filed 2024-11-14 | $80.71K derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | $19.76K 10-Q · filed 2024-08-12 | $40.35K 10-Q · filed 2024-08-12 | $60.95K derived: sum of 3 quarters · filed 2025-03-31 | $81.54K derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | $20.59K derived: 10-K 12 month − 3 quarters · filed 2025-03-31 | $41.19K derived: sum of 2 quarters · filed 2025-03-31 | $61.78K derived: sum of 3 quarters · filed 2025-03-31 | $82.38K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | $20.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $41.19K derived: sum of 2 quarters · filed 2025-03-31 | $61.78K derived: sum of 3 quarters · filed 2025-03-31 | $82.38K 10-K · filed 2025-03-31 |
| 2023-09-30 | $20.59K 10-Q · filed 2024-11-14 | $41.19K derived: sum of 2 quarters · filed 2024-11-14 | $61.78K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $20.59K 10-Q · filed 2024-08-12 | -$41.19K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |